No definition available.
Personality and behavioural disorders due to brain disease, damage and dysfunction
EFO MESH Endpoint Browser PheWeb
F5_PERSBEHORG
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
556 |
4. Check minimum number of eventsNone |
556 |
5. Include endpointsNone |
556 |
6. Filter based on genotype QC (FinnGen only) |
556 |
Control definitions (FinnGen only)
- Control exclude
- F5_ORGANIC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F04-F09
- Name in latin
- Perturbationes personae et modi se gerendi a morbo, laesione sive dysfunctione cerebri inductae
Similar endpoints
↥List of similar endpoints to
Personality and behavioural disorders due to brain disease, damage and dysfunction
based on the number of shared cases.
Similar with more cases:
- Organic, including symptomatic, mental disorders
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7855 | 2589 | 5124 |
| Only index persons | 5216 | 1732 | 3484 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | 0.07 | 0.14 |
| Only index persons | 0.11 | 0.06 | 0.13 |
| Median age at first event (years) | |||
| Whole population | 53.93 | 56.68 | 52.32 |
| Only index persons | 49.75 | 51.79 | 48.73 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 556 | 196 | 360 |
| Unadjusted period prevalence (%) | 0.13 | 0.07 | 0.16 |
| Median age at first event (years) | 50.47 | 46.88 | 52.43 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 511
- Matched controls
- 5104
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
+∞
170.6
154
*
F07.2
ICD-10 Finland
Postconcussional syndrome
+∞
145.9
133
*
F07.8
ICD-10 Finland
Other organic personality and behavioural disorders due to brain disease, damage and dysfunction
+∞
108.2
100
*
N05AX08
ATC
risperidone; systemic
17.7
93.5
154
121
N03AG01
ATC
valproic acid; systemic, rectal
16.4
85.0
144
119
T90.5
ICD-10 Finland
Sequelae of intracranial injury
77.3
85.0
95
15
F07.0
ICD-10 Finland
Organic personality disorder
+∞
74.8
70
*
N05AH04
ATC
quetiapine; oral
7.3
65.0
181
358
N05AH03
ATC
olanzapine; systemic
13.6
61.8
112
103
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
9.8
60.2
131
173
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
11.7
57.8
113
121
G40.9
ICD-10 Finland
Epilepsy, unspecified
16.7
53.0
87
62
N06AB04
ATC
citalopram; systemic
5.1
51.8
204
592
S06.2
ICD-10 Finland
Diffuse brain injury
45.8
50.1
61
15
F03
ICD-10 Finland
Unspecified dementia
49.1
47.4
57
13
N05AA02
ATC
levomepromazine; systemic
13.5
45.8
82
71
F32.9
ICD-10 Finland
Depressive episode, unspecified
6.3
45.4
134
271
N05BA01
ATC
diazepam; systemic, rectal
5.4
41.6
141
334
N05AD01
ATC
haloperidol; systemic
14.8
41.5
71
55
S06.3
ICD-10 Finland
Focal brain injury
28.0
38.9
53
21
F05.9
ICD-10 Finland
Delirium, unspecified
+∞
36.9
35
*
N05CD07
ATC
temazepam; oral
5.1
36.5
129
316
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
+∞
35.8
34
*
F29
ICD-10 Finland
Unspecified nonorganic psychosis
12.0
35.3
66
62
N03AF01
ATC
carbamazepine; oral, rectal
8.3
34.4
80
112
AA1AD
NOMESCO Finland
CT of head and brain
3.7
33.3
184
677
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
32.6
31
*
N03AF02
ATC
oxcarbazepine; oral
11.4
32.4
62
61
N05BA04
ATC
oxazepam; oral
3.6
31.9
179
665
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
16.6
31.1
50
33
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
15.1
31.0
52
38
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
6.4
29.6
83
151
N05BA06
ATC
lorazepam; systemic, sublingual
7.6
29.5
72
108
T36
ICD-10 Finland
Poisoning by systemic antibiotics
9.0
29.3
64
80
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
6.8
29.2
77
129
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
16.0
28.8
47
32
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
6.2
28.8
82
152
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
6.0
28.8
84
161
N06AX11
ATC
mirtazapine; oral
3.2
28.7
203
882
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.6
27.6
86
178
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
29.6
27.0
36
13
XA800
NOMESCO Finland
Neuropsychological investigation
7.4
26.5
65
98
N03AB02
ATC
phenytoin; systemic
39.0
26.5
33
9
N03AX09
ATC
lamotrigine; oral
8.5
25.5
57
74
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.2
24.9
70
127
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
24.7
131
452
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
10.1
24.3
49
53
N06DA03
ATC
rivastigmine; oral, transdermal
91.1
23.9
26
*
N03AX14
ATC
levetiracetam; systemic
10.4
23.8
47
49
F60.9
ICD-10 Finland
Personality disorder, unspecified
29.8
23.4
31
11
N06DX01
ATC
memantine; oral
56.8
23.3
27
5
F05.8
ICD-10 Finland
Other delirium
+∞
23.1
22
*
F07.1
ICD-10 Finland
Postencephalitic syndrome
+∞
23.1
22
*
N05CF01
ATC
zopiclone; oral
2.7
22.5
206
1017
A28
ICPC
Limited function/disability NOS
3.6
22.3
112
367
N06DA02
ATC
donepezil; oral
40.6
21.9
27
7
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.7
21.8
191
916
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
27.8
21.6
29
11
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
7.6
21.5
51
73
R41.0
ICD-10 Finland
Disorientation, unspecified
10.8
21.2
41
41
183
Kela drug reimbursment
Lamotrigin and topiramate
25.5
21.1
29
12
N06AB03
ATC
fluoxetine; oral
3.8
20.7
97
299
S06.0
ICD-10 Finland
Concussion
4.1
20.6
87
245
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
13.9
20.0
34
26
N06AX16
ATC
venlafaxine; oral
3.6
19.9
98
314
G30.1
ICD-10 Finland
Alzheimer disease with late onset
22.7
19.7
28
13
N05BE01
ATC
buspirone; oral
9.5
19.5
40
45
F06.7
ICD-10 Finland
Mild cognitive disorder
27.2
19.3
26
10
N05BA09
ATC
clobazam; oral
35.8
19.0
24
7
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.3
19.0
75
198
N03AX18
ATC
lacosamide; systemic
72.6
18.8
21
*
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.5
18.7
69
170
N06AB10
ATC
escitalopram; oral
3.0
18.7
123
487
3101A
ICD-9 Finland
Specific nonpsychotic mental disorders following organic brain damage, Organic personality syndrome
+∞
17.8
17
*
F01.9
ICD-10 Finland
Vascular dementia, unspecified
185.9
17.6
18
*
N03AE01
ATC
clonazepam; systemic
5.3
17.3
54
111
F10.20
ICD-10 Finland
Alcohol dependence currently independent
9.5
17.2
35
39
N06AB06
ATC
sertraline; oral
3.7
16.8
79
242
R53
ICD-10 Finland
Malaise and fatigue
2.7
16.6
127
549
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
16.6
164
816
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
6.4
16.3
43
72
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.6
16.1
78
245
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
5.4
16.1
49
98
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
21.8
16.1
23
11
N05AF03
ATC
chlorprothixene; systemic
7.8
15.7
36
49
F06.8
ICD-10 Finland
Other specified mental disorders due to brain damage and dysfunction and to physical disease
+∞
15.7
15
*
W19
ICD-10 Finland
Unspecified fall
3.5
15.5
76
241
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.8
15.5
68
197
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
7.3
15.4
37
54
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
4.2
15.4
60
156
N05AX12
ATC
aripiprazole; systemic
6.7
15.3
39
62
N05AD03
ATC
melperone; systemic
13.6
15.3
26
20
N07BB01
ATC
disulfiram; oral
5.4
15.3
46
91
N04AA02
ATC
biperiden; systemic
10.5
15.1
29
29
X59
ICD-10 Finland
Exposure to unspecified factor
2.6
15.0
123
551
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
4.3
14.9
57
145
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
10.2
14.9
29
30
85190
ICD-8 Finland
Cerebral laceration and contusion, Late effect
58.4
14.9
17
*
29350
ICD-8 Finland
Psychosis associated with other cerebral condition, Brain trauma
+∞
14.6
14
*
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
9.8
14.6
29
31
L28
ICPC
Limited function/disability (L)
2.9
14.6
97
381
G40
ICD-10 Finland
Epilepsy
17.6
14.4
22
13
A06AD11
ATC
lactulose; oral
2.7
14.4
108
457
N05BA02
ATC
chlordiazepoxide; systemic
7.4
14.0
33
47
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
+∞
13.6
13
*
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
6.2
13.4
36
62
NA1AD
NOMESCO Finland
Cervical spine CT examination
5.5
13.3
39
75
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.7
13.3
60
178
N05AN01
ATC
lithium; oral
9.1
13.1
27
31
F10.25
ICD-10 Finland
Alcohol dependence continuous use
9.1
13.1
27
31
N05AB03
ATC
perphenazine; systemic, rectal
5.5
13.0
38
73
N03AX16
ATC
pregabalin; oral
2.4
13.0
131
649
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
51.3
12.9
15
*
N06AX21
ATC
duloxetine; oral
3.3
12.9
67
222
N06AX03
ATC
mianserin; oral
4.8
12.9
43
96
S01.0
ICD-10 Finland
Open wound of scalp
3.4
12.6
62
197
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
17.9
12.6
19
11
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
25.0
12.5
17
7
F06.32
ICD-10 Finland
Organic depression
132.9
12.5
13
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
8.3
12.5
27
34
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
12.4
103
461
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.3
12.3
64
212
85100
ICD-8 Finland
Cerebral laceration and contusion, Without mention of open intracranial wound
38.5
12.3
15
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
27.4
12.1
16
6
N05AC02
ATC
thioridazine; oral
9.6
12.1
24
26
P20
ICPC
Memory disturbance
3.4
12.1
61
198
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
12.0
100
446
N05AF05
ATC
zuclopenthixol; systemic
15.1
11.9
19
13
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
66.4
11.6
13
*
S06.9
ICD-10 Finland
Intracranial injury, unspecified
23.5
11.6
16
7
F06.39
ICD-10 Finland
Organic mood syndrome UNS
+∞
11.5
11
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.8
11.4
79
315
F10.09
ICD-10 Finland
Alcohol intoxication UNS
7.9
11.3
25
33
R40.2
ICD-10 Finland
Coma, unspecified
13.1
11.2
19
15
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
8.3
11.2
24
30
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
11.5
11.1
20
18
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
11.5
11.1
20
18
F22.0
ICD-10 Finland
Delusional disorder
9.5
11.1
22
24
T74.1
ICD-10 Finland
Physical abuse
9.1
10.9
22
25
N06AX05
ATC
trazodone; oral
7.0
10.8
26
39
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
18.3
10.8
16
9
N05CD02
ATC
nitrazepam; oral
7.8
10.8
24
32
34599
ICD-8 Finland
Epilepsy, Other and unspecified
28.7
10.8
14
5
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
22.0
10.7
15
7
N05AB01
ATC
dixyrazine; systemic
9.5
10.6
21
23
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
14.6
10.5
17
12
29399
ICD-8 Finland
Psychosis associated with other cerebral condition, Other and unspecified cerebral condition
+∞
10.4
10
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.1
10.4
58
200
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
10.9
10.3
19
18
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.7
10.1
70
280
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
6.9
10.0
24
36
M03BX01
ATC
baclofen; systemic
12.5
9.9
17
14
N03AX11
ATC
topiramate; oral
7.2
9.9
23
33
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
26.6
9.8
13
5
N06AB08
ATC
fluvoxamine; oral
6.6
9.7
24
38
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
11.7
9.6
17
15
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
11.7
9.6
17
15
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.1
9.6
52
178
IGY02
NOMESCO Finland
Psychiatric monitoring contact
7.4
9.6
22
31
F39
ICD-10 Finland
Unspecified mood [affective] disorder
9.3
9.6
19
21
9070A
ICD-9 Finland
Late effects of injuries to the nervous system, Late effect of intracranial injury without mention of skull fracture
+∞
9.4
9
*
F06.0
ICD-10 Finland
Organic hallucinosis
+∞
9.4
9
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
22.1
9.4
13
6
F10.24
ICD-10 Finland
Alcohol depence active use
8.9
9.4
19
22
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
9.8
9.3
18
19
N06AG02
ATC
moclobemide; oral
4.2
9.2
34
85
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
9.3
9.1
18
20
N03AX12
ATC
gabapentin; oral
2.4
9.0
82
380
P99
ICPC
Psychological disorders other
5.7
9.0
25
46
S06.4
ICD-10 Finland
Epidural haemorrhage
24.5
8.9
12
5
N06AA06
ATC
trimipramine; systemic
5.8
8.8
24
43
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
9.7
8.8
17
18
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.2
8.8
32
79
N88
ICPC
Epilepsy
14.3
8.7
14
10
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.6
8.7
67
283
G31.0
ICD-10 Finland
Circumscribed brain atrophy
50.8
8.7
10
*
N05AH02
ATC
clozapine; systemic
6.0
8.7
23
40
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
11.8
8.6
15
13
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
28.0
8.5
11
*
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
20.4
8.5
12
6
S72.0
ICD-10 Finland
Fracture of neck of femur
4.5
8.4
29
68
F05.1
ICD-10 Finland
Delirium superimposed on dementia
91.4
8.4
9
*
G30.0
ICD-10 Finland
Alzheimer disease with early onset
91.4
8.4
9
*
N06DA04
ATC
galantamine; oral
91.4
8.4
9
*
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
91.4
8.4
9
*
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
13.0
8.4
14
11
N06AA09
ATC
amitriptyline; systemic
2.7
8.4
59
238
N06BA04
ATC
methylphenidate; oral
8.7
8.4
17
20
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
8.3
8
*
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
+∞
8.3
8
*
29320
ICD-8 Finland
Psychosis associated with other cerebral condition, Epilepsy
+∞
8.3
8
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
6.7
8.2
20
31
F20.9
ICD-10 Finland
Schizophrenia, unspecified
5.5
8.2
23
43
P29
ICPC
Psychological sympt/compl other
3.6
8.1
35
101
R42
ICD-10 Finland
Dizziness and giddiness
2.0
8.1
114
639
E8190
ICD-8 Finland
Motor vehicle traffic accident of unspecified nature, Driver of motor vehicle other than motorcycle
11.9
8.1
14
12
3459X
ICD-9 Finland
Epilepsy, unspecified
33.9
8.1
10
*
N06AA12
ATC
doxepin; systemic
3.6
8.1
35
102
Y09
ICD-10 Finland
Assault by unspecified means
22.4
8.0
11
5
S02.10
ICD-10 Finland
Fracture of base of skull, closed
22.4
8.0
11
5
F61.0
ICD-10 Finland
Mixed personality disorders
7.4
8.0
18
25
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
7.9
7.9
17
22
TAB00
NOMESCO Finland
Lumbar puncture
3.9
7.9
31
83
R51.80
ICD-10 Finland
Headache
2.3
7.9
75
355
WX892
NOMESCO Finland
Monitored bed care
2.9
7.9
47
173
F32.1
ICD-10 Finland
Moderate depressive episode
3.6
7.8
34
99
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
11.0
7.8
14
13
N05AA01
ATC
chlorpromazine; systemic, rectal
6.5
7.8
19
30
N03AX15
ATC
zonisamide; oral
45.6
7.7
9
*
Z02.4
ICD-10 Finland
Examination for driving licence
0.4
7.7
37
814
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
7.6
87
449
EBA00
NOMESCO Finland
Extraction of tooth
1.8
7.6
160
1034
30180
ICD-8 Finland
Personality disorders, Immatura
18.7
7.6
11
6
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.4
7.6
35
107
A86
ICD-10 Finland
Unspecified viral encephalitis
25.4
7.6
10
*
N05AC01
ATC
periciazine; systemic
25.4
7.6
10
*
F60.2
ICD-10 Finland
Dissocial personality disorder
25.4
7.6
10
*
N06AB05
ATC
paroxetine; oral
3.3
7.6
36
113
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.2
7.6
39
130
TKC20
NOMESCO Finland
Catheterisation of bladder
2.7
7.4
48
186
3453A
ICD-9 Finland
Epilepsy, Grand mal status
+∞
7.3
7
*
F06.6
ICD-10 Finland
Organic emotionally labile [asthenic] disorder
+∞
7.3
7
*
K08.3
ICD-10 Finland
Retained dental root
2.9
7.3
43
157
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
7.3
86
448
F41.8
ICD-10 Finland
Other specified anxiety disorders
5.9
7.3
19
33
G40.89
ICD-10 Finland
Other epilepsy
16.0
7.2
11
7
N28
ICPC
Limited function/disability (N)
7.5
7.2
16
22
X58
ICD-10 Finland
Exposure to other specified factors
2.1
7.2
80
408
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.0
7.2
27
70
34510
ICD-8 Finland
Epilepsy, """"Grand mal""""
30.4
7.2
9
*
F99
ICD-10 Finland
Mental disorder, not otherwise specified
6.7
7.2
17
26
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
8.1
7.1
15
19
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
12.2
7.1
12
10
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
12.2
7.1
12
10
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
7.1
63
289
B18.2
ICD-10 Finland
Chronic viral hepatitis C
8.9
7.1
14
16
R47.0
ICD-10 Finland
Dysphasia and aphasia
8.9
7.1
14
16
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
10.2
7.1
13
13
R11
ICD-10 Finland
Nausea and vomiting
2.7
7.0
48
190
W10
ICD-10 Finland
Fall on and from stairs and steps
3.3
7.0
34
109
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
4.7
7.0
22
48
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.0
6.9
39
136
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
14.0
6.9
11
8
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
14.0
6.9
11
8
WX730
NOMESCO Finland
Conventional respirator
5.4
6.8
19
36
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
9.5
6.8
13
14
S01.3
ICD-10 Finland
Open wound of ear
9.5
6.8
13
14
SPAT1229
SPAT
Assessment of need for aid
2.7
6.8
45
177
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
4.8
6.8
21
45
AAK00
NOMESCO Finland
Cranioplasty
40.5
6.8
8
*
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
40.5
6.8
8
*
N03AG04
ATC
vigabatrin; oral
40.5
6.8
8
*
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
40.5
6.8
8
*
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
40.5
6.8
8
*
31099
ICD-8 Finland
Borderline mental retardation, Other and unspecified
40.5
6.8
8
*
R45.1
ICD-10 Finland
Restlessness and agitation
40.5
6.8
8
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.4
6.7
31
96
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
5.3
6.7
19
37
N05AL01
ATC
sulpiride; systemic
8.0
6.6
14
18
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
6.6
50
212
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
6.6
94
526
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
7.0
6.5
15
22
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
7.0
6.5
15
22
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.6
6.5
21
47
Y96.9
ICD-10 Finland
Unspecified type of accident
6.3
6.5
16
26
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
3.4
6.5
30
93
A04
ICPC
Weakness/tiredness general
2.2
6.5
64
309
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
7.5
6.4
14
19
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
70.6
6.4
7
*
V03AA02
ATC
NA
70.6
6.4
7
*
34598
ICD-8 Finland
Epilepsy, Alia definita
70.6
6.4
7
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.4
6.4
51
222
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.0
6.4
36
127
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
6.4
65
318
R1260
NOMESCO Finland
Evaluation of communicative skills
6.1
6.3
16
27
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
6.1
6.3
16
27
R4120
NOMESCO Finland
Occupational therapy
2.8
6.3
40
151
T51.0
ICD-10 Finland
Toxic effect: Ethanol
18.3
6.3
9
5
29330
ICD-8 Finland
Psychosis associated with other cerebral condition, Intercranial neoplasm
+∞
6.3
6
*
29398
ICD-8 Finland
Psychosis associated with other cerebral condition, Alia definita
+∞
6.3
6
*
8510A
ICD-9 Finland
Cerebral laceration and contusion, Cortex (cerebral) contusion without mention of open intracranial wound[CONTUSIO CEREBRI NON COMP,EI TIETOA TAJUTTOMUUDESTA]
+∞
6.3
6
*
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
+∞
6.3
6
*
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
+∞
6.3
6
*
F06.33
ICD-10 Finland
Organic mood syndrome
+∞
6.3
6
*
30188
ICD-8 Finland
Personality disorders, Alia definita
+∞
6.3
6
*
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
7.2
6.2
14
20
S06.8
ICD-10 Finland
Other intracranial injuries
27.0
6.2
8
*
V01.9
ICD-10 Finland
Pedestrian injured in collision with pedal cycle, Unspecified whether traffic or nontraffic accident
27.0
6.2
8
*
W17
ICD-10 Finland
Other fall from one level to another
3.1
6.2
32
108
N30.0
ICD-10 Finland
Acute cystitis
2.2
6.2
60
288
S82.6
ICD-10 Finland
Fracture of lateral malleolus
3.0
6.2
33
114
OAB43
SPAT
NA
0.3
6.2
14
427
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
6.1
83
458
Y94.0
ICD-10 Finland
Accident at home
6.8
6.1
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009466) Valproate [Moles/volume] in Serum or Plasma
76
59
14.75
80.83
4.7
4.8
umol/l
361.0
356.4
0.07
61
50
(3019309) Folate [Moles/volume] in Red Blood Cells
149
710
2.50
18.64
1.9
1.7
nmol/l
1000.5
1130.2
1.14
108
541
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
293
2013
1.96
13.48
7.0
7.1
mmol/l
1.2
1.2
0.05
245
1709
(3023368) Bacteria identified in Blood by Culture
197
1202
1.99
12.62
5.6
4.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
272
1854
1.91
12.50
6.7
6.4
mmol/l
1.2
1.2
0.15
243
1677
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
133
711
2.14
12.15
2.0
1.8
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
20
40
5.14
9.62
1.7
1.1
mosm/kgh2o
284.8
282.2
0.18
15
30
(3018418) pH of Serum or Plasma
184
1186
1.82
9.45
3.8
4.2
ph
7.4
7.4
0.56
30
220
(3028707) Methadone [Presence] in Urine by Screen method
27
72
3.89
9.14
2.4
2.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
94
490
2.10
8.99
1.9
1.7
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
21
6.80
8.92
1.3
2.2
umol/l
154.3
85.9
—
6
11
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
60
264
2.42
8.59
1.6
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
93
493
2.06
8.48
2.0
1.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
198
1353
1.72
8.07
3.0
2.7
u/l
50.6
57.4
2.76
184
1258
(3012095) Magnesium [Moles/volume] in Serum or Plasma
116
676
1.90
8.05
3.1
3.7
mmol/l
0.8
0.8
0.12
104
637
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
370
4296
0.58
7.89
4.9
5.0
mmol/l
2.7
2.7
0.13
322
3966
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
188
1286
1.70
7.54
3.3
2.1
u/l
305.9
381.6
0.31
175
1212
(1761868) Lipid panel - Serum or Plasma
97
1574
0.53
7.29
3.1
2.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
361
4193
0.60
7.23
4.4
4.4
mmol/l
1.4
1.4
1.31
312
3865
(40758558) Short blood count panel - Blood
156
1026
1.72
7.17
7.7
7.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
201
1416
1.65
7.13
5.3
6.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
347
4059
0.61
6.98
3.9
4.0
mmol/l
1.4
1.3
1.89
300
3725
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
226
1655
1.61
6.78
2.1
1.9
pmol/l
93.9
94.4
0.06
131
884
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
367
4219
0.61
6.57
4.3
4.5
mmol/l
4.5
4.6
0.20
319
3914
(3011288) Drugs identified in Urine by Screen method
30
107
2.90
6.51
2.7
3.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
88
502
1.89
6.45
1.9
1.6
—
—
—
0
0
(4198724)
11
18
6.21
6.44
2.4
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
72
386
1.99
6.32
1.8
2.1
nmol/l
353.3
368.2
0.26
65
359
(3024561) Albumin [Mass/volume] in Serum or Plasma
236
1770
1.58
6.28
5.7
5.1
g/l
34.1
35.5
2.61
213
1657
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
291
2295
1.56
6.17
6.1
6.7
umol/l
9.8
11.9
5.08
269
2178
(3002032) Base excess in Venous blood by calculation
71
384
1.97
6.08
3.6
3.8
mmol/l
2.8
1.8
1.21
58
312
(3001604) Monocytes [#/volume] in Blood
268
2080
1.55
6.07
7.1
6.0
e9/l
0.6
0.6
0.95
223
1803
(3006315) Basophils [#/volume] in Blood
269
2091
1.55
6.04
7.1
6.0
e9/l
0.0
0.0
0.98
225
1821
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
66
1140
0.52
5.88
2.4
2.9
ug/l
0.6
0.8
1.27
43
734
(3013115) Eosinophils [#/volume] in Blood
275
2158
1.54
5.85
8.0
6.2
e9/l
0.2
0.2
0.62
231
1910
(3019069) Monocytes/100 leukocytes in Blood
257
1991
1.54
5.78
7.9
6.5
%
8.5
8.8
0.63
235
1868
(3019198) Lymphocytes [#/volume] in Blood
272
2135
1.53
5.75
7.6
6.1
e9/l
1.9
1.9
0.09
227
1900
(21494755) Public health laboratory ask at order entry panel
11
414
0.25
5.70
1.1
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
184
1327
1.58
5.67
3.3
3.5
mmol/l
2.3
2.3
0.81
144
1162
(3014111) Lactate [Moles/volume] in Serum or Plasma
70
386
1.93
5.67
7.0
8.6
mmol/l
1.4
1.4
0.16
64
368
(3022096) Basophils/100 leukocytes in Blood
249
1924
1.53
5.62
6.2
6.2
%
0.6
0.7
2.50
229
1799
(3006504) Eosinophils/100 leukocytes in Blood
255
1981
1.53
5.61
6.7
6.2
%
2.6
2.9
1.27
235
1847
(3002030) Lymphocytes/100 leukocytes in Blood
260
2040
1.51
5.39
6.8
6.3
%
26.8
27.4
0.35
234
1904
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
34
4.19
5.38
2.4
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
49
242
2.12
5.37
1.9
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
197
1459
1.54
5.34
4.3
3.4
u/l
31.5
34.2
0.57
182
1393
(1001926) Buprenorphine [Presence] in Urine by Screen method
31
126
2.54
5.29
2.3
2.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
299
2431
1.50
5.13
11.6
9.5
e9/l
4.7
4.1
2.36
256
2121
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
388
0.27
5.10
1.2
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
148
1037
1.58
5.09
2.2
2.1
mg/l
2.8
3.1
0.81
120
895
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
259
0.22
5.05
1.2
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
254
2007
1.49
4.96
6.6
6.1
%
58.0
57.3
0.39
230
1888
(3026782) Osmolality of Urine
124
840
1.61
4.89
2.7
2.9
mosm/kgh2o
548.6
577.5
0.62
107
713
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
108
1564
0.61
4.88
4.2
4.1
%
21.7
21.2
0.13
44
720
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
21
73
2.95
4.80
1.8
1.3
e6/l
27.9
17.1
0.25
14
56
(3003396) Base excess in Arterial blood by calculation
82
501
1.74
4.78
7.7
8.7
mmol/l
2.4
1.1
2.03
64
406
(3026008) Bacteria identified in Urine by Culture
155
1116
1.54
4.68
3.9
3.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
379
3268
1.50
4.63
8.2
8.0
u/l
79.2
79.4
0.03
352
3061
(3013826) Glucose [Moles/volume] in Serum or Plasma
305
2522
1.46
4.60
7.1
5.0
mmol/l
6.6
6.8
0.82
287
2365
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
215
1662
1.48
4.60
4.9
3.6
ng/l
31.8
36.6
0.40
163
1167
(3031040) Bacteria [#/volume] in Urine by Automated count
323
2709
1.46
4.47
6.3
4.2
e6/l
705.5
1253.4
—
10
49
(3006184) Hemoglobin [Mass/volume] in Capillary blood
23
89
2.65
4.35
2.8
2.3
g/l
137.5
129.0
0.77
17
65
(3021960) Folate [Moles/volume] in Serum or Plasma
136
968
1.53
4.29
1.6
1.5
nmol/l
16.9
20.8
2.68
115
815
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
88
565
1.66
4.27
2.4
1.8
%
1.8
1.5
1.97
72
502
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
123
860
1.55
4.20
1.7
1.7
pmol/l
467.7
412.5
1.39
101
730
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
70
425
1.74
4.17
4.4
3.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
95
628
1.62
4.11
2.3
2.4
g/l
2.5
2.3
1.67
87
587
(3003458) Phosphate [Moles/volume] in Serum or Plasma
88
572
1.64
4.07
5.5
6.0
mmol/l
1.0
1.0
0.19
81
538
(3000764) Benzodiazepines [Presence] in Urine
33
156
2.18
4.07
2.3
2.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
61
360
1.78
4.01
7.8
10.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
28
3.98
3.98
2.7
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
33
159
2.14
3.89
2.3
2.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
78
498
1.66
3.87
3.4
2.5
%
2.0
1.8
0.63
66
457
(3016879) Cocaine [Presence] in Urine
32
153
2.16
3.85
2.4
2.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
78
500
1.65
3.81
7.9
8.7
kpa
5.4
5.1
1.48
73
479
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
53
305
1.81
3.79
2.9
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
27
121
2.29
3.79
2.2
1.5
ug/g
234.2
287.4
0.55
14
73
(3027801) Oxygen [Partial pressure] in Arterial blood
78
501
1.65
3.78
7.9
8.6
kpa
12.1
12.0
0.08
73
483
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
202
1595
1.42
3.68
2.6
2.3
nmol/l
72.1
76.5
1.14
179
1422
(3044290) Cell count panel - Cerebral spinal fluid
18
68
2.70
3.59
2.0
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
223
1798
1.40
3.58
8.6
9.5
inr
1.1
1.3
3.71
60
511
(3025941) Bacteria identified in Stool by Culture
41
222
1.91
3.55
1.3
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
32
159
2.07
3.51
2.3
2.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
13
6.22
3.51
3.1
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
35
181
1.99
3.46
2.0
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
23
101
2.33
3.39
3.5
3.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
97
674
1.53
3.38
1.8
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
27
3.75
3.36
2.6
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
128
2.16
3.34
1.4
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
127
939
1.45
3.26
4.0
3.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
65
415
1.64
3.24
2.1
2.5
g/l
0.2
0.2
0.03
59
386
(3019150) Specific gravity of Urine by Refractometry
120
881
1.46
3.19
4.5
3.8
kg/l
1.0
1.0
0.17
14
120
(3027944) Amphetamines [Presence] in Urine
31
159
2.00
3.15
2.4
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
87
602
1.53
3.09
2.3
2.4
%
19.6
23.6
1.99
74
531
(3017143) Hepatitis C virus Ab [Presence] in Serum
73
486
1.58
3.07
1.9
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
157
1964
0.72
3.05
4.3
4.8
ug/l
3.3
2.3
0.49
118
1759
(3002256) Pathology report gross observation
29
531
0.52
3.03
1.4
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
115
847
1.45
3.00
3.4
3.9
ng/l
1433.3
268.5
0.38
92
672
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
22
438
0.48
2.96
1.5
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
125
940
1.42
2.91
1.8
1.8
mg/l
1.3
1.3
0.01
100
735
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
13
5.43
2.87
1.0
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
190
1542
1.35
2.78
3.8
3.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
23
111
2.12
2.76
1.5
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
14
5.04
2.73
1.1
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
18
368
0.47
2.63
1.0
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
48
300
1.65
2.62
5.1
3.6
mmol/l
2.1
1.6
0.50
38
227
(3018095) Leukocytes [#/volume] in Urine
184
1501
1.34
2.57
4.8
3.8
e6/l
95.7
160.7
0.53
136
1079
(3021879) Hepatitis B virus core Ab [Presence] in Serum
48
302
1.64
2.56
1.8
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
130
1639
0.73
2.56
2.1
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
324
2863
1.31
2.54
5.1
4.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
163
1310
1.34
2.51
3.8
3.3
e6/l
288.3
117.1
0.31
128
1013
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
5
8
6.29
2.37
1.0
1.0
umol/l
3.7
4.5
—
5
8
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
46
2.64
2.36
1.4
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
93
690
1.42
2.33
2.4
2.4
umol/l
12.2
13.3
0.78
88
645
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
29
163
1.82
2.31
2.1
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
32
186
1.76
2.29
1.9
2.0
ug/l
3.1
1.9
0.26
26
169
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
335
2997
1.29
2.28
4.6
3.7
pmol/l
14.5
14.8
0.83
295
2706
(40761535) Cells panel - Urine sediment
52
344
1.56
2.28
3.4
3.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
23
3.51
2.27
2.1
3.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
18
3.92
2.25
1.9
3.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
18
3.92
2.25
1.9
3.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
49
322
1.57
2.22
5.2
3.5
kpa
5.2
5.1
0.29
44
301
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
9
5.59
2.21
1.8
1.9
umol/l
21.9
17.0
—
5
9
(3008152) Bicarbonate [Moles/volume] in Arterial blood
43
274
1.62
2.21
8.0
6.8
mmol/l
25.8
24.4
1.53
38
256
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
14
61
2.33
2.15
1.1
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
48
317
1.56
2.13
5.3
3.6
ph
7.4
7.4
—
6
34
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47
309
1.57
2.13
3.0
4.0
mmol/l
1.2
1.2
0.06
38
278
(3014271) Vancomycin [Susceptibility]
8
25
3.23
2.10
5.3
2.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
93
703
1.39
2.09
3.2
3.3
mmol/l
2.4
2.5
0.29
75
623
(3000850) Epithelial cells [#/volume] in Urine
114
892
1.35
2.07
2.8
2.6
e6/l
6.2
5.2
0.24
100
785
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
10
5.03
2.07
1.0
1.8
ug/l
0.7
1.2
—
5
10
(3023520) Reticulocytes [#/volume] in Blood
54
369
1.51
2.07
2.7
2.4
e9/l
78.6
69.8
0.77
37
290
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
92
700
1.37
1.99
3.5
3.0
e6/l
3.4
1.6
0.69
47
399
(3006653) Thiamine [Moles/volume] in Blood
7
21
3.36
1.97
1.3
1.3
nmol/l
124.4
151.4
—
7
21
(3001019) Free T4 and TSH panel - Serum or Plasma
7
172
0.40
1.94
1.7
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
52
0.00
1.89
0.0
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
86
2.01
1.86
2.1
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
86
2.01
1.86
2.1
1.3
—
—
—
0
0
(3019225) pH of Specimen
57
405
1.45
1.82
3.6
4.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
17
87
1.98
1.81
4.2
2.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
452
4730
0.75
1.77
34.9
21.2
g/l
133.0
137.4
6.73
442
4653
(3009261) Glucose [Presence] in Urine by Test strip
235
2058
1.24
1.75
4.2
3.5
estimate
0.0
0.0
0.00
38
363
(3010813) Leukocytes [#/volume] in Blood
452
4728
0.76
1.74
34.8
21.1
e9/l
7.3
6.7
5.68
438
4590
(3026361) Erythrocytes [#/volume] in Blood
452
4727
0.76
1.72
34.7
21.1
e12/l
4.4
4.5
5.77
438
4593
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
47
0.00
1.71
0.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
47
0.00
1.71
0.0
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
452
4726
0.76
1.71
34.6
21.0
fl
91.2
91.1
0.12
443
4655
(3035941) MCH [Entitic mass]
452
4726
0.76
1.71
34.5
21.0
pg
30.4
30.4
0.00
443
4654
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
48
0.00
1.70
0.0
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
388
4132
0.79
1.70
4.8
4.6
mmol/l
6.0
6.0
0.00
333
3777
(36304419) Bacteria [Presence] in Urine
139
1149
1.28
1.69
3.9
3.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
232
2035
1.24
1.69
5.6
4.9
estimate
0.0
0.0
0.00
41
387
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
49
0.00
1.69
0.0
1.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
452
4724
0.76
1.68
34.5
21.1
e9/l
253.0
244.1
1.82
438
4600
(3009214) Lutropin [Units/volume] in Serum or Plasma
23
134
1.75
1.68
1.7
1.3
u/l
5.9
8.2
0.61
15
103
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
31
198
1.60
1.63
2.5
1.7
g/l
1.6
1.5
0.21
26
178
(3029937) Albumin [Presence] in Urine by Test strip
130
1071
1.28
1.62
4.8
3.8
estimate
0.0
0.0
0.69
38
370
(3019060) Gas panel - Arterial blood
42
288
1.49
1.62
5.0
4.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
14
70
2.02
1.60
1.1
1.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
231
2035
1.23
1.60
4.2
3.5
estimate
0.0
0.0
0.00
39
381
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
65
487
1.38
1.57
11.6
6.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
369
3939
0.81
1.56
6.8
5.9
mmol/mol
41.1
40.2
0.70
327
3666
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
51
368
1.42
1.53
2.5
2.4
ug/l
4.3
8.7
1.71
42
326
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
57
420
1.40
1.52
3.1
2.6
u/l
28.9
34.7
0.75
52
362
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
27
2.61
1.51
1.3
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
27
2.61
1.51
1.3
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
86
1.88
1.51
2.6
2.6
%
17.6
16.4
—
9
47
(44806118)
11
51
2.18
1.51
1.2
1.6
—
—
—
0
0
(44790048)
11
51
2.18
1.51
1.2
1.6
—
—
—
0
0
(44790047)
11
51
2.18
1.51
1.2
1.6
—
—
—
0
0
(44790049)
11
51
2.18
1.51
1.2
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
33
220
1.53
1.46
2.5
2.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
21
125
1.70
1.45
6.5
3.7
mmol/l
3.8
4.0
0.60
16
112
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
22
2.74
1.43
1.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
22
2.74
1.43
2.7
2.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
22
2.74
1.43
1.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
20
118
1.72
1.42
1.1
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
21
126
1.69
1.41
6.4
2.8
mmol/l
24.6
24.6
0.01
21
110
(3052851) Hemolysis interference index of Serum or Plasma
21
126
1.69
1.41
3.9
3.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
20
119
1.70
1.39
1.1
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
210
1855
1.21
1.37
10.2
9.7
e9/l
0.0
0.0
0.26
161
1520
(3030467) Casts [#/volume] in Urine by Automated count
141
1196
1.24
1.37
3.9
3.2
e6/l
0.6
0.5
0.22
106
897
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
17
2.95
1.36
1.4
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
73
571
1.32
1.35
1.5
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
20
120
1.69
1.35
1.1
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
34
233
1.49
1.34
5.1
3.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
98
1.76
1.32
1.1
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
24
2.51
1.30
2.5
1.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
16
91
1.78
1.29
4.5
4.4
kpa
5.3
5.1
0.73
16
91
(3027315) Oxygen [Partial pressure] in Blood
16
91
1.78
1.29
4.5
4.4
kpa
8.6
8.5
0.13
16
91
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
34
2.37
1.29
2.0
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
378
3997
0.83
1.29
19.6
13.3
ml/min/173m2
86.9
81.0
5.03
300
3307
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
43
312
1.41
1.28
2.7
4.1
ng/l
76.2
83.9
0.56
35
286
(3047181) Lactate [Moles/volume] in Blood
22
138
1.62
1.27
4.2
6.3
mmol/l
1.2
1.3
0.21
17
121
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
227
0.56
1.25
1.1
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
36
2.24
1.24
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
45
2.01
1.23
1.1
1.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
367
3884
0.83
1.22
25.3
15.6
%
39.0
40.4
2.04
221
2816
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
37
2.18
1.21
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
24
156
1.56
1.21
6.7
4.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
71
565
1.29
1.18
28.1
23.3
inr
1.3
1.3
—
10
68
(3011985) Renin [Units/volume] in Plasma
10
50
2.02
1.16
1.7
1.3
mu/l
31.9
31.0
—
10
45
(3001122) Ferritin [Mass/volume] in Serum or Plasma
195
1734
1.19
1.16
2.9
2.7
ug/l
140.4
149.3
0.19
169
1601
(3044640) Blood type and Crossmatch panel - Blood
155
1350
1.20
1.15
3.1
2.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
20
2.51
1.15
2.0
2.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
36
0.00
1.14
0.0
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
41
1.96
1.09
1.1
1.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
65
519
1.28
1.07
3.2
2.9
umol/l
5.4
9.7
2.34
46
468
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
33
2.13
1.05
1.3
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
33
2.13
1.05
1.3
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
46
1.97
1.04
1.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
46
1.97
1.04
1.2
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
46
1.97
1.04
1.2
1.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
16
98
1.65
1.04
6.6
4.3
mg/l
18.7
26.2
—
10
67
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
32
230
1.41
1.03
1.2
1.2
iu/ml
58.4
119.6
—
7
88
(4024509)
7
34
2.07
1.03
3.4
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
46
353
1.33
1.01
1.6
3.3
ng/l
221.9
229.8
0.03
38
319
(3026493) Urate [Moles/volume] in Serum or Plasma
99
1158
0.82
1.00
2.8
2.7
umol/l
352.9
7343.5
4.63
77
998
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
49
1.85
0.99
1.2
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
29
0.00
0.98
0.0
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
33
242
1.38
0.96
8.6
11.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
80
665
1.24
0.95
2.4
2.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
340
3589
0.86
0.95
32.3
18.4
g/l
332.8
333.3
0.42
334
3571
(3024891) Influenza virus A+B Ag [Presence] in Specimen
18
118
1.54
0.91
1.5
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
71
1.70
0.89
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
23
161
1.45
0.87
2.9
2.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
30
2.01
0.87
1.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
80
1.64
0.85
1.2
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
31
1.94
0.84
2.5
3.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
45
1.79
0.84
2.3
3.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
105
1.54
0.82
1.6
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
32
1.88
0.82
1.8
3.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
32
1.88
0.82
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
172
1.41
0.82
2.2
1.8
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
13
81
1.62
0.81
1.4
1.2
u/l
36.2
36.5
0.00
13
72
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
118
1036
1.17
0.81
2.9
2.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
147
0.61
0.80
1.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.3
—
1.0
—
0
24
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
48
1.67
0.79
1.8
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
26
0.00
0.78
0.0
1.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
86
738
1.19
0.77
3.5
2.8
e6/l
1.6
1.1
0.51
40
435
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
34
1.77
0.76
1.8
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
49
398
1.25
0.74
2.2
1.9
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
38
1.85
0.73
1.3
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
38
1.85
0.73
1.3
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
440
4527
0.86
0.73
12.5
10.7
u/l
27.5
28.3
0.37
418
4375
(3044889) 12 lead EKG panel
280
2965
0.89
0.73
3.9
3.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
125
1.45
0.73
1.9
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
108
0.55
0.73
2.0
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
25
2.01
0.72
1.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
39
1.80
0.72
1.3
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
429
4420
0.87
0.72
21.3
13.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
40
1.76
0.71
1.0
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
109
1.48
0.71
1.1
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
58
1.56
0.70
1.3
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
14
93
1.52
0.69
1.2
2.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
122
1358
0.87
0.69
3.8
4.1
mg/mmol
6.1
9.6
0.84
78
881
(4094501)
7
116
0.60
0.68
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
42
1.67
0.68
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
13
191
0.67
0.68
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
63
532
1.21
0.68
1.7
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
43
1.63
0.67
1.0
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
37
458
0.79
0.66
3.2
4.4
ug/l
3.4
40.9
1.37
28
382
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
44
1.60
0.65
1.3
1.3
nmol/l
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
129
1.41
0.64
1.2
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
54
638
0.83
0.63
1.3
1.3
u/ml
1.2
13.1
3.94
14
254
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
104
1.45
0.62
1.1
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
58
679
0.84
0.62
1.4
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
26
200
1.31
0.61
1.2
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
2.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
116
1282
0.88
0.59
3.0
3.4
mg/l
38.6
213.2
1.33
76
843
(40768443) Skin Pathology biopsy report
13
185
0.69
0.59
1.3
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
31
247
1.27
0.57
2.6
2.8
e6/l
0.2
0.2
0.01
31
238
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
18
132
1.37
0.57
2.2
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
43
357
1.22
0.56
2.0
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
170
1572
1.12
0.55
4.5
3.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
106
1172
0.88
0.55
1.7
1.7
mmol/l
1.6
1.4
0.92
87
990
(1761482) Bacteria [#/volume] in Urine by Culture
8
125
0.63
0.55
3.8
4.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
82
1.47
0.54
1.0
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
337
3498
0.90
0.54
28.9
17.9
%
13.9
13.7
1.47
331
3435
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
61
1.48
0.54
2.4
3.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
61
1.48
0.54
1.3
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
63
1.43
0.52
1.3
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
63
1.43
0.52
1.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
63
1.43
0.52
1.3
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
64
1.41
0.51
1.3
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
64
1.41
0.51
1.3
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
40
334
1.21
0.51
2.7
2.8
g/l
66.1
66.6
0.13
34
309
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
75
1.47
0.50
1.0
1.2
—
1.1
—
0
6
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
75
1.47
0.50
6.4
3.8
%
59.4
59.5
0.02
11
75
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
17
127
1.35
0.50
2.5
1.4
g/l
0.3
0.2
0.62
17
122
(3017446) Testosterone [Moles/volume] in Serum or Plasma
51
440
1.17
0.47
2.7
2.2
nmol/l
11.6
13.6
0.92
41
390
(3003694) ABO and Rh group [Type] in Blood
103
1128
0.89
0.46
1.3
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
77
1.44
0.45
1.2
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
51
1.38
0.44
1.4
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
447
4368
1.11
0.44
26.5
16.8
mmol/l
139.1
139.7
3.90
434
4253
(3007164) IgA [Mass/volume] in Serum or Plasma
73
813
0.88
0.44
1.4
1.4
g/l
2.5
2.5
0.02
43
515
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
5
31
1.62
0.43
1.4
1.2
%
39.4
32.6
—
5
23
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
5
33
1.52
0.41
1.8
1.8
—
806.6
—
0
12
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
15
0.00
0.41
0.0
1.1
—
15.8
—
0
10
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
4.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.5
—
—
—
0
0
(44806420)
0
16
0.00
0.41
0.0
2.5
—
—
—
0
0
(4035726)
31
367
0.83
0.40
1.4
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
141
1.28
0.40
1.2
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.7
—
59.1
—
0
18
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
50
567
0.87
0.39
4.2
4.5
%
30.2
31.4
0.31
34
389
(3021788) Differential panel - Synovial fluid
9
68
1.33
0.37
1.3
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
68
1.33
0.37
1.3
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
302
2912
1.08
0.37
5.1
3.3
u/l
63.8
54.1
0.87
279
2723
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
98
1.33
0.37
1.2
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
37
318
1.17
0.37
2.8
4.6
%
4.2
0.4
—
9
90
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
431
4216
1.09
0.37
24.1
14.5
mg/l
29.1
24.6
1.80
370
3360
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
60
667
0.89
0.36
1.4
1.3
iu/ml
18.4
33.5
1.13
15
217
(3026389) Candida sp identified in Specimen by Organism specific culture
6
41
1.47
0.36
2.0
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
12
90
1.34
0.35
1.9
1.7
iu/l
3.0
7.4
—
6
27
(3017181) Myelocytes/100 leukocytes in Blood
41
358
1.16
0.35
3.6
4.6
%
1.9
0.9
0.62
14
126
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
73
1.37
0.34
6.8
3.2
e9/l
5.8
4.7
—
10
73
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
6
44
1.37
0.34
1.2
1.4
nmol/l
0.4
0.4
—
6
32
(40761536) Microorganisms panel - Urine sediment
39
340
1.16
0.34
3.7
3.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
447
4385
1.09
0.34
26.4
16.9
mmol/l
4.0
4.0
0.58
434
4262
(3025159) Blasts/100 leukocytes in Blood
36
312
1.16
0.33
3.9
4.9
%
0.0
0.0
0.80
11
97
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
12
91
1.32
0.33
2.8
2.2
u/l
153.4
4594.5
—
6
33
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
16
127
1.27
0.33
1.2
1.1
—
7.8
—
0
14
(3013707) Erythrocyte sedimentation rate by Westergren method
319
3091
1.07
0.33
4.0
4.1
mm/h
14.5
12.0
1.72
283
2843
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
7
52
1.35
0.31
1.3
1.2
nmol/l
0.7
0.5
—
7
46
(3017732) Neutrophils [#/volume] in Blood
34
296
1.16
0.31
8.9
2.8
e9/l
5.4
4.0
1.49
25
238
(36660697) Celiac disease serology panel - Serum
27
311
0.86
0.28
1.5
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
65
1.23
0.27
1.0
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
71
0.70
0.26
1.4
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
73
0.68
0.26
5.2
2.7
u/ml
4.9
3.6
—
5
68
(3004588) Protein electrophoresis panel - Serum or Plasma
30
263
1.15
0.26
1.8
2.7
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
73
1.24
0.25
1.1
4.1
—
2567.7
—
0
10
(3021440) Promyelocytes/100 leukocytes in Blood
37
331
1.12
0.24
3.9
4.8
%
0.0
0.2
3.54
12
112
(3022621) pH of Urine by Test strip
30
265
1.14
0.23
4.3
2.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
138
1316
1.06
0.23
3.6
3.3
ng/l
1835.1
1364.7
0.34
111
1122
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
38
1.32
0.23
4.8
2.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
39
1.28
0.23
1.4
1.9
%
10.4
11.9
—
5
39
(3037522) Nuclear Ab [Titer] in Serum
59
545
1.09
0.22
1.5
1.3
titre
408.9
401.0
—
9
119
(3045788) Cell count panel - Pleural fluid
5
42
1.19
0.21
2.0
1.4
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.2
—
2.7
—
0
5
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(4015189)
0
11
0.00
0.21
0.0
2.8
—
—
—
0
0
(4133840)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
11
0.00
0.21
0.0
7.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
51
470
1.09
0.21
3.5
2.5
ug/g
177.0
124.8
0.34
43
378
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
48
1.25
0.20
1.0
1.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
48
1.25
0.20
1.3
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
14
0.00
0.20
0.0
1.1
—
3.2
—
0
14
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
9.2
—
0
14
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
144
0.83
0.20
1.0
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
16
136
1.18
0.20
2.7
1.4
g/l
1.2
1.2
0.16
16
131
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
81
1.24
0.18
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
128
1.18
0.18
2.9
2.0
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
7
59
1.19
0.18
1.9
1.6
g/l
34.9
30.9
—
7
53
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
59
1.19
0.18
2.9
3.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
205
1992
1.04
0.17
4.9
4.1
—
—
—
0
0
(4034850)
16
138
1.16
0.17
14.3
8.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
20
176
1.14
0.17
5.3
3.5
g/l
0.2
0.2
0.82
11
76
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
1.1
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
110
1.18
0.17
1.8
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
63
1.11
0.17
2.0
2.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
45
417
1.08
0.17
1.4
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
82
1.22
0.17
1.9
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
111
1.17
0.15
1.2
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
32
293
1.10
0.15
1.7
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
263
2576
1.04
0.15
2.6
2.9
—
—
—
0
0
(3000492) Spirometry study
40
429
0.93
0.15
1.5
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
28
257
1.09
0.13
1.1
1.3
—
47.5
—
0
16
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
107
0.84
0.13
1.6
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
143
1.12
0.11
2.2
2.6
g/l
3.2
3.1
0.01
11
114
(4062490)
5
44
1.14
0.10
1.2
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
45
1.11
0.10
9.0
2.2
—
—
—
0
0
(4146454)
5
48
1.04
0.09
6.0
3.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
378
3743
1.03
0.09
5.8
4.4
mu/l
2.0
2.2
0.31
337
3408
(40768806) Pleura Pathology biopsy report
6
54
1.11
0.09
1.3
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
107
1.12
0.08
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
60
0.83
0.08
1.0
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
63
0.79
0.08
1.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
19
205
0.92
0.08
2.1
2.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
185
1.08
0.08
1.1
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
90
875
1.03
0.08
1.4
1.2
u/ml
0.7
1.6
1.98
22
239
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
68
1.03
0.08
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
75
0.80
0.07
1.8
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
76
1.05
0.07
1.0
1.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
8
76
1.05
0.07
2.5
1.9
g/l
0.4
0.9
—
8
58
(4010399)
30
316
0.95
0.07
1.5
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
82
0.85
0.07
1.4
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
86
1.05
0.07
1.2
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
90
0.89
0.07
1.4
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
21
222
0.94
0.05
2.5
3.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
136
1373
0.99
0.03
3.1
3.3
mmol/l
7.4
8.0
0.64
107
1137
(40760892) CBC W Ordered Manual Differential panel - Blood
93
916
1.02
0.03
6.9
4.9
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
11
102
1.08
0.03
1.1
1.8
nmol/l
1.7
0.9
—
6
86
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
138
0.94
0.02
3.5
2.8
u/ml
0.3
0.4
—
5
75
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
152
1.05
0.02
2.2
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
152
1.05
0.02
2.2
2.5
g/l
3.8
3.8
0.07
11
111
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
152
1.05
0.02
2.2
2.5
g/l
7.6
7.4
0.15
11
116
(3013512) EKG study
128
1267
1.01
0.02
4.2
3.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
114
1128
1.01
0.02
3.7
3.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
36
352
1.02
0.01
2.7
2.9
ml/min/173m2
66.6
63.9
0.13
12
148
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
143
1.05
0.01
1.6
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
48
486
0.99
0.01
1.5
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
94
1.06
0.00
1.5
2.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
57
568
1.00
0.00
1.7
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
23
229
1.00
0.00
1.3
1.3
u/ml
168.1
326.4
0.57
23
203
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
134
0.97
0.00
2.1
2.6
ug/min
107.5
85.7
—
6
76
(3045414) Leukocytes [Presence] in Urine
18
180
1.00
0.00
1.7
1.9
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
14
136
1.03
0.00
3.1
2.6
%
81.2
90.5
0.85
14
127
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
95
0.95
0.00
1.0
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
2.2
—
0
8
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
59
1.02
0.00
6.7
4.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
9.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
92
0.98
0.00
1.0
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.4
—
52.4
—
0
8
(3045142) Bone marrow Pathology biopsy report
5
51
0.98
0.00
1.6
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
82
0.97
0.00
1.3
1.8
%
51.5
64.9
—
8
82
(40760888) Immunoglobulin light chains.free panel - Serum
9
94
0.96
0.00
1.6
4.2
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
5
0.00
0.00
0.0
3.0
—
116.8
—
0
5
(40762365) Oxygen content in Arterial blood by calculation
0
6
0.00
0.00
0.0
3.0
—
15.7
—
0
6
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
79
0.88
0.00
2.3
3.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
7
69
1.01
0.00
1.0
1.1
—
18.2
—
0
13
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
4.7
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
19.7
—
0
5
(4306422)
6
66
0.91
0.00
1.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
80
1.00
0.00
1.4
1.6
—
—
—
0
0
(4268621)
5
49
1.02
0.00
3.2
2.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
50
1.00
0.00
2.0
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
5.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
75
0.93
0.00
2.0
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
61
0.98
0.00
1.8
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_PERSBEHORG and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_PERSBEHORG | 3.369 [2.8, 4.05] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.593 |
During the follow-up period (1.1.1998 — 31.12.2019), 534 out of 1449 females with F5_PERSBEHORG died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_PERSBEHORG | 4.112 [3.58, 4.73] | < 0.001 |
| Birth year | 0.984 [0.98, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1321 out of 3047 males with F5_PERSBEHORG died.
Mortality risk
Mortality risk for people of age
years, who have F5_PERSBEHORG.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.306% | 0.696% |
| 5 | 2.45% | 4.059% |
| 10 | 5.875% | 10.45% |
| 15 | 10.264% | 18.921% |
| 20 | 17.597% | 30.434% |
Relationships between endpoints
↥Index endpoint: F5_PERSBEHORG – Personality and behavioural disorders due to brain disease, damage and dysfunction
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data